AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Prime Medicine, Inc.

$4.72 +$1.19 (+33.71%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$5.24
Day Range
$4.67$5.20
Year Range
$2.67$5.91
Market Cap
856.1M
AVG Volume
4.01M
Trailing/Forward PE
-4.29/-
PEG ratio
0.15
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
NASDAQUS
Revenue (USD) · A
02M4M6M20212022202320242025
PRME Revenue (USD) by year
PeriodRevenue (USD)
20254.63M
20242.98M
20230
20220
20210
Net Income (USD) · A
-300M-200M-100M020212022202320242025
PRME Net Income (USD) by year
PeriodNet Income (USD)
2025-201.14M
2024-195.88M
2023-198.13M
2022-128.18M
2021-165.37M
Operating Income (USD) · A
-300M-200M-100M020212022202320242025
PRME Operating Income (USD) by year
PeriodOperating Income (USD)
2025-208.35M
2024-202.47M
2023-204.79M
2022-116.54M
2021-84.47M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PRME

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 6 Nov 2026.

Prime Medicine, Inc.
PRME
Stockpicker

Video analysis: PRME

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PRME

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.